- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
- 10-K Annual report
- 10.15 Employment Agreement
- 10.16 Amended and Restated Employment Agreement
- 10.17 Amended and Restated Employment Agreement
- 10.18 Amended and Restated Employment Agreement
- 10.37 Third Amended and Restated License Agreement
- 10.41 Amendment to Us Co-promotion Agreement
- 10.43 Amended License to Collaboration Agreement
- 10.45 Amendment No. 1 to Facility Agreement
- 10.46 Amendment No. 2 to Facility Agreement
- 23.1 Consent of Pricewaterhousecoopers LLP
- 31.1 Section 302 CEO Certification
- 31.2 Section 302 CFO Certification
- 32.1 Section 906 Certifications
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Report of ZymoGenetics, Inc. (the “Company”) on Form 10-K for the period ended December 31, 2009 as filed with the Securities and Exchange Commission on the date hereof (the “Form 10-K”), I, Douglas E. Williams, Chief Executive Officer and James A. Johnson, Chief Financial Officer, of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Form 10-K fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C 78m or 78o(d)); and
(2) The information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: February 26, 2010
/s/ DOUGLAS E. WILLIAMS |
Douglas E. Williams |
Chief Executive Officer |
/s/ JAMES A. JOHNSON |
James A. Johnson |
Chief Financial Officer |